- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Rigel Pharmaceuticals Inc+ Add to Watchlist
RIGL:US4.7500 USD 0.2300 5.09%
As of 20:10:00 ET on 03/10/2014.
Company Profile for Rigel Pharmaceuticals Inc (RIGL)
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. The Company's research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms.
Rigel Pharmaceuticals Inc
Key Executives for Rigel Pharmaceuticals Inc (RIGL)
|James M GowerChairman/CEO||Raul R RodriguezPresident/COO|
|Ryan D MaynardExec VP/CFO||Elliott B GrossbardExec VP/Chief Medical Officer|
|Donald G PayanExec VP/Pres:Discov & Research||Dolly A VanceExec VP:Affairs/Secy/Gen Cnsl|